Is an estimated glomerular filtration rate better than creatinine to be incorporated into the end-stage liver disease score?

Table 3 Relationship between estimated glomerular filtration rate, total bilirubin, international normalized ratio and model for end-stage liver disease score as a predictor of in-hospital mortality

Model	Variable	Odds ratio (95% CI)	P value	χ2	-2 Log Likelihood
Model 1	MELD	1.25 (1.23-1.27)	< 0.001	2198.32	2773.90
Model 2	Total bilirubin1	2.25 (2.05-2.48)	< 0.001	2161.45	2810.77
	INR1	6.14 (4.56-8.27)	< 0.001
	eGFR (MDRD-4)1	0.22 (0.20-0.25)	< 0.001
Model 3	Total bilirubin1	2.17 (1.97-2.40)	< 0.001	2293.82	2664.79
	INR1	5.95 (4.39- 8.06)	< 0.001
	eGFR (MDRD-6)1	0.19 (0.17-0.22)	< 0.001
Model 4	Total bilirubin1	2.26 (2.05-2.48)	< 0.001	2199.16	2773.07
	INR1	6.28 (4.65-8.49)	< 0.001
	eGFR (CKD-EPI)1	0.20 (0.18-0.23)	< 0.001

¹Loge value. Statistical comparison was performed with logistic regression analysis. MELD: Model for end-stage liver disease; INR: International normalized ratio; eGFR: Estimated glomerular filtration rate; MDRD: Modification of diet in renal disease; MDRD-4; 4-variable MDRD; MDRD-6: 6-variable MDRD; CKD-EPI: The chronic kidney disease epidemiology collaboration.